Takeda Ventures β Full Portfolio
17 tracked investments Β· listed companies and verified rows first
BiotechBranford, US
Donmienne Leung(Manager)Ian Taylor(Manager)Stephen Bloch(CEO and Manaager)
BoardDerek Yoon(Manager)Denis Patrick(Manager)
Board seatJasmina MarjanovicΒ· per SEC Form D
Co-investorsPfizer Venture InvestmentsSolasta Ventures
Co-investorsAllianz XLG Technology VenturesMcKesson VenturesP5 Health VenturesPerot Jain
HealthtechSaratoga Springs, US
Daniel T. Pickett III(Executive Officer, Director)Timothy Koehler(Executive Officer)Greg Stephen(Executive Officer)
BoardHolly Benson(Director)Mary Langowski(Director)Peter Dorsman(Director)
Co-investorsClaritas CapitalWhat If Ventures
Aspen RxHealth operates a community of pharmacists to deliver clinical pharmacy care and medication support for patients and health plan members.
Digital HealthHealthtechSaaS
Co-investorsBessemer Venture PartnersFlare Capital Partners
Co-investorsAlta PartnersARCH Venture PartnersDC Investment PartnersLongwood FundNextech InvestPathway to Cures+6 more
Biofourmis provides technology-enabled solutions and a platform for AI-driven in-home patient care, using wearable biosensors and remote monitoring to deliver and transition patients across levels of care.
AI & Machine LearningDigital HealthHealthtech
Kuldeep Singh Rajput(Founder)in
Co-investorsIntel Capital
Boulder provides medication-assisted treatment for addiction through licensed specialists who prescribe buprenorphine, supported by dedicated care teams offering medical care, peer recovery coaching, and care coordination accessible via a digital platform.
Digital HealthHealthtechMental HealthBoulder, US
Co-investorsAdvance Venture PartnersGreycroftLaerdal Million Lives FundTusk Venture Partners
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+7 more
Cambridge, MA biotech developing engineered tRNA "protein editing" therapeutics for nonsense-mutation diseases; reported shut down in 2025.
Cambridge, US
Leslie J Williams(Executive Officer, Director)
BoardBenjamin Chen(Director)Seiji Miyahara(Director)Sacha Mann(Director)David Moskowitz(Director)Steven Gillis(Director)in
Co-investorsARCH Venture Partners8VCTaiho Ventures, LLC
ISHI Health operates a digital health platform and virtual care program for cardiac care, using EHR data integration and AI-driven insights to support personalized care pathways and patient engagement.
AI & Machine LearningDigital HealthHealthtech
Co-investorsHomebrewBBG VenturesCoalition Operators
Clinical-stage immuno-oncology company developing antibodies derived from the immune systems of 'Elite' cancer responders.
BiotechHouston, US
Alice Bexon(Executive Officer)Clifford J. Stocks(Director, Executive Officer)Kamal D. Puri(Executive Officer)Chris Russell(Executive Officer)Russ Hawkinson(Executive Officer)
BoardSteven Gillis(Director)in
Co-investors3B Future Health FundCanaan PartnersGreatPoint VenturesRiverVest Venture PartnersARCH Venture PartnersBering Capital+3 more
Oshi provides virtual gastrointestinal care delivered by gastroenterologists, dietitians, and gut-brain specialists to patients seeking treatment for GI conditions.
Digital HealthHealthtech
Sam Holliday(CEO)
Co-investorsBessemer Venture PartnersCVS Health VenturesFlare Capital PartnersFrist Cressey VenturesKoch Disruptive TechnologiesOak HC/FT
BiotechWaltham, US
James W. Broderick(Executive Officer, Director)John Hennessy(Executive Officer)Karen Hong(Director)James Lee(Director)Stephen Hoffman(Director)
BoardJens Eckstein(Director)
Co-investorsSR One Capital ManagementPfizer VenturesVertex Ventures HC
Developed site-specific protein conjugation and linker technologies; acquired by Catalent Pharma Solutions in 2014.
BiotechEmeryville, US
DAVID RABUKA(Executive Officer, Director)MICHAEL BLANK(Executive Officer)KAREN M BOEZI(Executive Officer, Director)
BoardJ GORDON FOULKES(Director)EDWARD MCCRACKEN(Director)BARRY LITTLEJOHNS(Director)
Co-investorsMission Biocapital
HealthtechPasadena, US
Ramon Lizardo(Executive Officer)Christopher Maloney(Executive Officer, Director, Promoter)Marc Eckstein(Executive Officer, Director)
BoardJeff Trost(Director)inBruce Meadows(Director)
Co-investorsLaerdal Million Lives Fund
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.